title: Drug use evaluation of cefepime in the first affiliated hospital of Bengbu medical college: a retrospective and prospective analysis.
abstract: BACKGROUND
  Cefepime is a fourth generation cephalosporin antimicrobial. Its extended antimicrobial activity and infrequent tendency to engender resistance make it popular for the treatment of infections. However, proper use of cefepime has not been studied adequately. In this study, we used a retrospective cohort and a prospective cohort to evaluate the usage pattern, adverse effects and cost-effectiveness of cefepime by conducting a drug use evaluation (DUE) program in the First Affiliated Hospital of Bengbu Medical College, Anhui, China.
  
  
  METHODS
  The DUE criteria for cefepime were established by applying literature review and expert consultation, an effective method to promote interventions that will improve patient outcomes and the cost-effectiveness of drug therapy. According to the criteria, we performed a cross-sectional retrospective (cycle A) study on 96 hospitalized patients who received cefepime treatment and a prospective (cycle B) study on 111 hospitalized patients with cefepime treatment intervention. After identifying problems with usage and completing a cefepime use evaluation for cycle A, 2 months of educational intervention among professionals were given and a more effective and rational system of cefepime use was set up. During the 2 months, the lectures were arranged and attendance of prescribers was required.
  
  
  RESULTS
  The data from cycle A showed that the biggest problem was irrational prescription of cefepime; bacterial culture and drug sensitivity tests for cefepime were also not carried out. Following 2 months of educational intervention among professionals, the results for cycle B showed that the correct indication rate was 94.59%, compared with 84.38% in cycle A. Use of bacterial culture and sensitivity tests also improved, by 88.29% in cycle B compared with 65.22% in cycle A. Compared with cycle A, the significantly improved items (P < 0.05) in cycle B were blood examination, liver function monitoring, renal function monitoring, dose and duration, dosing frequency and correct medication combinations.
  
  
  CONCLUSIONS
  Cefepime can be used appropriately for the right indications and in a cost-effective way for the majority of patients through educational intervention, including the special precautions that must be followed for appropriate dosing frequency and duration. DUE programs will become one model of hospital pharmacy care and part of the plan for continuous improvements to the quality of health care in China.
authors.affiliation: Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China. sir_shi@126.com
authors.forename: Qingping
authors.initials: Q
authors.lastname: Shi
authors.forename: Feng
authors.initials: F
authors.lastname: Ding
authors.forename: Ran
authors.initials: R
authors.lastname: Sang
authors.forename: Yan
authors.initials: Y
authors.lastname: Liu
authors.forename: HaoYu
authors.initials: H
authors.lastname: Yuan
authors.forename: Meiling
authors.initials: M
authors.lastname: Yu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001291:Attitude of Health Personnel; D001521:Behavior Therapy; D000077723:Cefepime; D002511:Cephalosporins / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002681:China; D015331:Cohort Studies; D003362:Cost-Benefit Analysis; D017723:Drug Utilization Review; D004501:Education, Medical; D005260:Female; D006761:Hospitals; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000077723:Cefepime
references.citation: Am J Hosp Pharm. 1994 Feb 15;51(4):531-2
references.pmid: 8017425
references.citation: Am J Hosp Pharm. 1977 Mar;34(3):251-4
references.pmid: 857669
references.citation: Crit Care Med. 2001 Apr;29(4 Suppl):N87-91
references.pmid: 11292881
references.citation: Clin Infect Dis. 2001 Nov 15;33(10):1661-7
references.pmid: 11595982
references.citation: QJM. 2006 Jun;99(6):397-406
references.pmid: 16682440